Quick-blast radiation for prostate cancer shows promise in small pilot study
NCT ID NCT03486821
First seen May 19, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This pilot study tested a new way of giving radiation for early-stage prostate cancer using fewer, stronger doses (ultra-hypofractionation). The main goal was to see if this approach causes less urinary side effects than standard radiation. The study enrolled 13 men with low-risk prostate cancer and tracked their urinary function and cancer control over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY STAGE PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Kansas Medical Center/ Cancer Center
Kansas City, Kansas, 66190, United States
Conditions
Explore the condition pages connected to this study.